Home | | Genetics and Molecular Biology | ras-fos-jun Pathway

Chapter: Genetics and Molecular Biology: Oncogenesis, Molecular Aspects

ras-fos-jun Pathway

The ras protein is one well-studied oncogene, partially because it is encoded by the oncogene Weinberg found in the transformation assays of the NIH 3T3 cells.

The ras-fos-jun Pathway

 

The ras protein is one well-studied oncogene, partially because it is encoded by the oncogene Weinberg found in the transformation assays of the NIH 3T3 cells. More extensive studies have shown that an activated ras product is found in 10 to 20% of all human cancers. Humans possess three different ras products, N-ras, which is encoded on chromosome 1, H-ras from chromosome 11, and K-ras from chro-mosome 12. Even Saccharomyces cerevisiae possesses two ras products.

 

In order that these ras proteins be able to respond to extracellular and transmembrane receptors, they are held on the inner surface of the plasma membrane by farnesyl. This is a fatty acid, membrane-loving, intermediate of the cholesterol biosynthetic pathway. The farnesyl is attached to the carboxy terminal cysteine of ras. The same principle of attaching a membrane-soluble molecule to a protein is used to attach the outer membrane of Escherichia coli to the peptidoglycan layer. In yeast, the same enzymes that transfer the fatty acid to the cysteine of ras for membrane attachment also modify a mating-type factor. Al-though ras proteins bind nucleotides and have a GTPase activity and are therefore G proteins, they function as monomers, whereas many other G proteins function as heterotrimers.

The G proteins are activated by the binding of a GTP nucleotide. When they hydrolyze this to GDP, the activation ceases. Not surpris-ingly, then, oncogenic ras mutants do not hydrolyze the GTP normally. Some have mutations in the GTP-binding site, and others have lost the ability to bind to an accessory protein, GAP, for GTPase activating protein (Fig. 23.12). It is the GAP protein that interacts with the growth factor receptor. When the receptor is occupied, the GAP protein is phosphorylated. It therefore ceases to stimulate hydrolysis of GTP bound to ras. This leaves ras in an activated state. As a result, it activates a phosphorylation pathway that ultimately phosphorylates and acti-vates the c-jun protein.


Figure 23.12 Pathway for activation of ras protein


Phosphorylated c-jun then forms a heterodimer with c-fos protein. This heterodimer is also known as AP-1 and it activates transcription from a wide collection of promoters.

 

The fos and jun oncogenes were identified on retroviruses and the cellular analogs were then found using their homology to the viral forms. These proteins are typical leucine zipper transcriptional activa-tors and they bind to the same DNA sequence as the yeast general amino acid regulator protein GCN4. The structure of the fos and jun leucine zippers favors a heterodimer rather than homodimer formation due to the presence of opposite charges on the two helices. The theme of heterodimer formation regulating cell growth is common and both leucine zipper proteins and helix-loop-helix proteins participate in this form of regulation.


Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Genetics and Molecular Biology: Oncogenesis, Molecular Aspects : ras-fos-jun Pathway |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.